Rapid work is on to find vaccines and cures to fight the epidemic coronavirus. According to the World Health Organization (WHO), there are 124 potential vaccines for Covid-19. 10 of which are at the clinical trial level. While in India it is expected to start in 6 months. There are few government projects in countries like China, while most private pharma companies are looking for vaccines. However, this raises the question that why so many companies are engaged in this endeavor and why everyone wants to find the vaccine. The reason is money. The company that will find the vaccine is sure to be rewarded.

JP Morgan's property worth so many crores gets seized

After inventing any vaccine or medicine, money is not made only from the sale of it, but also from the patent rights, a lot of profit is made. The world's largest vaccine maker produces 1.5 billion doses annually. However, the Serum Institute of India (SII) has publicly supported the non-patenting of the vaccine. Gilead Science, whose drug remadevisor has been approved to be used by the Food and Drug Administration (FDA) of the US for treatment against Covid-19, also owns the antiviral drug Sofosubuvir that is used to treat hepatitis C.

Ajit Jogi's condition critical, know what doctors say

Any company that offers medical solutions for Covid-19 gets tremendous value. As seen in the case of Moderna only last week. This American company, which has not sold a single product till date, saw a huge jump of $ 30 billion in market capital and 30 percent in shares. A day earlier, the company was reported to be successful in the first phase of manufacturing the Covid-19 vaccine. The company was launched 10 years ago. Now at a price of $ 76 per share, it is increasing by $ 1.34 billion. When its publicly listed shares are trading in the low $ 60 range.

CM Chandrashekhar Rao said this about formation day of Telangana